A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)
Clinical trial NCT01526057 · COMPLETED
Trial details
- NCT number
- NCT01526057
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-20
- Primary completion
- 2013-08-13
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.